Boston – September 21, 2026 -- Cellular Intelligence, a Boston-based AI company building a universal foundation model of cell signaling, has appointed Turing Award laureate Yann LeCun, Moderna co-founder Robert "Bob" Langer, BioInnovation Institute CEO Jens Nielsen and Helmholtz Munich computational health director Fabian Theis to its Scientific Advisory Board. Langer also joins the company's Board of Directors as an observer.

Washington – September 21, 2026 -- Arc XP, the media technology platform built inside The Washington Post, launched Arc XP Compass, a personalization engine that rebuilds news home pages and section fronts around each returning reader while leaving editorial priorities in newsroom hands.

New York – September 21, 2026 -- Africa's push for greater control over its resources and a stronger voice in global governance took center stage as business leaders, heads of state, and investors gathered for the fifth edition of Unstoppable Africa, held alongside the 81st UN General Assembly session at the Marriott Marquis in Times Square.

Dallas – September 21, 2026 -- Solidion Technology, Inc. (NASDAQ: STI) has combined its Chairman and CEO roles, appointing Jaymes Winters to the dual position effective September 16, 2026, while naming Mark N. Schwartz as Lead Independent Director.

New Taipei City – September 21, 2026 -- UD info's DB Series SSD Drives have achieved FIPS 140-3 validation from the National Institute of Standards and Technology's Cryptographic Module Validation Program, with NIST Certificate No. 5479 issued August 12, 2026, confirming Overall Level 2 status.

Singapore – September 21, 2026 -- MetaOptics Ltd (Catalist: 9MT) has secured an investment facility of up to US$10 million from White Lion Capital LLC, marking the Singapore-listed metalens maker's first institutional backer from the United States.

Shanghai – September 20, 2026 -- Abbisko Therapeutics Co., Ltd. (HKEX: 02256.HK) reported that its oral FGFR2/3 inhibitor lavengratinib achieved a mean increase of 2.4 cm/year in annualized height velocity among children with achondroplasia in the lowest-dose cohort of a Phase II trial, with a 100% responder rate.

New York – September 20, 2026 -- More than 100 CEOs, heads of state and UN leaders concluded the 2026 UN Private Sector Forum in New York calling for faster public-private cooperation to unlock clean-energy investment, citing grid bottlenecks, regulatory uncertainty and financing gaps as the main barriers to deployment at scale.

Atlanta and Carlsbad, Calif. – September 20, 2026 -- Field Medical, Inc. reported 12-month outcomes from its first-in-human Field PULSE trial showing 94.2% per-vein durability for pulmonary vein isolation using an optimized waveform, with results published in JACC: Clinical Electrophysiology and presented as a Late-Breaking Clinical Trial at HRX Live 2026.

Atlanta and Los Angeles – September 20, 2026 -- StimCardio Medical reported that patients treated with non-invasive median nerve stimulation (MNS) after atrial fibrillation (AF) ablation showed 90.0% freedom from atrial arrhythmias at six months, compared with 80.8% for those receiving sham treatment, though the difference did not reach statistical significance. The randomized, double-blind, sham-controlled NeuroPulse pilot study was presented as late-breaking clinical science at HRX Live 2026 and simultaneously published in the peer-reviewed journal Heart Rhythm.